Robert Kristal - BioRestorative Therapies Chief Officer
| BRTX Stock | USD 1.53 0.05 3.38% |
Insider
Robert Kristal is Chief Officer of BioRestorative Therapies
| Age | 56 |
| Address | 40 Marcus Drive, Melville, NY, United States, 11747 |
| Phone | 631 760 8100 |
| Web | https://www.biorestorative.com |
BioRestorative Therapies Management Efficiency
The company has return on total asset (ROA) of (0.5324) % which means that it has lost $0.5324 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1712) %, meaning that it created substantial loss on money invested by shareholders. BioRestorative Therapies' management efficiency ratios could be used to measure how well BioRestorative Therapies manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.92 in 2024. Return On Capital Employed is likely to rise to -1.45 in 2024. At this time, BioRestorative Therapies' Total Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 320.5 K in 2024, despite the fact that Non Currrent Assets Other are likely to grow to (842.6 K).Similar Executives
| Showing other executives | INSIDER Age | ||
| Kirk Coleman | Tff Pharmaceuticals | 50 | |
| Glenn Mattes | Tff Pharmaceuticals | 67 | |
| Mark Lappe | Inhibrx | 57 | |
| Susan MS | Eliem Therapeutics | N/A | |
| MBA MD | Eliem Therapeutics | 63 | |
| Robert MBA | Eliem Therapeutics | 56 | |
| Dale Christensen | Tff Pharmaceuticals | N/A | |
| Anthony Hickey | Tff Pharmaceuticals | N/A | |
| James JD | Eliem Therapeutics | 58 | |
| Harlan Weisman | Tff Pharmaceuticals | 72 | |
| Erin Lavelle | Eliem Therapeutics | 47 | |
| Jo PalmerPhillips | Eliem Therapeutics | N/A | |
| Paul Manley | Tff Pharmaceuticals | N/A | |
| BS CPA | Inhibrx | 42 | |
| Quinn Deveraux | Inhibrx | N/A | |
| Christopher Cano | Tff Pharmaceuticals | 53 | |
Management Performance
| Return On Equity | -0.17 | ||||
| Return On Asset | -0.53 |
BioRestorative Therapies Leadership Team
Elected by the shareholders, the BioRestorative Therapies' board of directors comprises two types of representatives: BioRestorative Therapies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioRestorative. The board's role is to monitor BioRestorative Therapies' management team and ensure that shareholders' interests are well served. BioRestorative Therapies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioRestorative Therapies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Francisco Silva, VP Scientist | ||
| Robert Paccasassi, Vice Compliance | ||
| Stephen Kilmer, Investor Officer | ||
| Wayne MD, Clinical Board | ||
| Robert Kristal, Chief Officer | ||
| Lance Alstodt, President Board |
BioRestorative Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BioRestorative Therapies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.17 | ||||
| Return On Asset | -0.53 | ||||
| Operating Margin | (9.79) % | ||||
| Current Valuation | (2.44 M) | ||||
| Shares Outstanding | 6.92 M | ||||
| Shares Owned By Insiders | 26.32 % | ||||
| Shares Owned By Institutions | 13.74 % | ||||
| Number Of Shares Shorted | 74.44 K | ||||
| Price To Earning | (1.79) X | ||||
| Price To Book | 1.06 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for BioRestorative Stock Analysis
When running BioRestorative Therapies' price analysis, check to measure BioRestorative Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRestorative Therapies is operating at the current time. Most of BioRestorative Therapies' value examination focuses on studying past and present price action to predict the probability of BioRestorative Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRestorative Therapies' price. Additionally, you may evaluate how the addition of BioRestorative Therapies to your portfolios can decrease your overall portfolio volatility.